X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4279) 4279
Newsletter (242) 242
Publication (192) 192
Book Review (28) 28
Magazine Article (26) 26
Book Chapter (7) 7
Conference Proceeding (7) 7
Book / eBook (5) 5
Transcript (4) 4
Newspaper Article (3) 3
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
niacin (2650) 2650
humans (1666) 1666
animals (1331) 1331
niacin - pharmacology (1258) 1258
nicotinic acids - pharmacology (1080) 1080
index medicus (799) 799
male (785) 785
isoniazid (736) 736
nicotinic acids (711) 711
pharmacology & pharmacy (678) 678
rats (545) 545
female (516) 516
isomerism (431) 431
research (386) 386
tuberculosis (362) 362
niacin - analogs & derivatives (346) 346
niacin - therapeutic use (341) 341
atherosclerosis (291) 291
nicotinic-acid (287) 287
nicotinic acid (285) 285
mycobacterium tuberculosis - drug effects (284) 284
cholesterol (283) 283
niacin - administration & dosage (281) 281
pharmacology (281) 281
niacinamide (273) 273
mice (266) 266
extended-release niacin (264) 264
middle aged (262) 262
adult (247) 247
biochemistry & molecular biology (235) 235
niacin - metabolism (232) 232
hypolipidemic agents - therapeutic use (224) 224
hypolipidemic agents - pharmacology (194) 194
coronary-heart-disease (188) 188
metabolism (187) 187
analysis (182) 182
aged (178) 178
statins (164) 164
risk factors (159) 159
streptomycin - pharmacology (159) 159
cholesterol, hdl - blood (154) 154
dose-response relationship, drug (151) 151
niacin - adverse effects (150) 150
lipids (149) 149
guinea pigs (146) 146
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (143) 143
drug therapy, combination (138) 138
drugs (136) 136
physiological aspects (136) 136
in vitro techniques (135) 135
diet (132) 132
health aspects (131) 131
nicotinic acid isomers/effects (130) 130
cholesterol, ldl - blood (129) 129
dyslipidemia (128) 128
reports (128) 128
triglycerides - blood (127) 127
high-density-lipoprotein (126) 126
liver - metabolism (125) 125
niacin - chemistry (123) 123
hyperlipidemias - drug therapy (121) 121
bacillus (120) 120
cholesterol - blood (118) 118
prevention (118) 118
cardiac & cardiovascular systems (117) 117
drug therapy (116) 116
chemistry, medicinal (115) 115
endocrinology & metabolism (114) 114
time factors (110) 110
toxicology (110) 110
dyslipidemias - drug therapy (108) 108
lipid metabolism (105) 105
cardiovascular (102) 102
liver - drug effects (102) 102
treatment outcome (102) 102
inflammation (101) 101
niacinamide - pharmacology (101) 101
aminosalicylic acid - pharmacology (100) 100
lipids - blood (100) 100
cardiovascular disease (99) 99
cell biology (99) 99
delayed-action preparations (98) 98
rats, sprague-dawley (97) 97
rabbits (96) 96
cardiovascular-disease (95) 95
nad (93) 93
kinetics (92) 92
diabetes (90) 90
peripheral vascular disease (90) 90
density-lipoprotein cholesterol (89) 89
lipoproteins (89) 89
hypolipidemic agents - adverse effects (88) 88
therapy (88) 88
hypolipidemic agents - administration & dosage (86) 86
fatty acids, nonesterified - blood (85) 85
low density lipoproteins (85) 85
rats, wistar (85) 85
anti-bacterial agents (83) 83
mycobacterium tuberculosis (83) 83
nicotinamide (83) 83
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3746) 3746
Italian (240) 240
German (200) 200
Russian (113) 113
French (99) 99
Spanish (45) 45
Japanese (42) 42
Polish (25) 25
Hungarian (10) 10
Chinese (9) 9
Dutch (8) 8
Romanian (7) 7
Czech (6) 6
Portuguese (5) 5
Bulgarian (3) 3
Swedish (2) 2
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmacology, ISSN 0014-2999, 03/2014, Volume 726, Issue 1, pp. 57 - 65
The ischemic stroke cascade is composed of several pathophysiological events, providing multiple targets for pharmacological intervention. JM-20... 
Neuroprotection | Mitochondria | Stroke | Cell death | JM-20 | OXIDATIVE STRESS | GUTTIFERONE-A | CEREBELLAR GRANULE CELLS | PERMEABILITY TRANSITION | GLUTAMATE TOXICITY | PHARMACOLOGY & PHARMACY | HYDROGEN-PEROXIDE | CYTOCHROME-C RELEASE | PC12 CELLS | CEREBRAL-ISCHEMIA | Neurons - pathology | Hydrolysis - drug effects | Mitochondrial Swelling - drug effects | Calcium - metabolism | Stroke - complications | Membrane Potential, Mitochondrial - drug effects | Niacin - pharmacology | PC12 Cells | Neuroprotective Agents - pharmacology | Liver - drug effects | Neurons - metabolism | Potassium Cyanide - pharmacology | Cell Death - drug effects | Neurons - drug effects | Mitochondrial Proton-Translocating ATPases - antagonists & inhibitors | Pentylenetetrazole - pharmacology | Brain Ischemia - complications | Benzodiazepines - pharmacology | Cytochromes c - secretion | Dihydropyridines - chemistry | Neuroprotective Agents - chemistry | Glutamic Acid - pharmacology | Liver - metabolism | Hydrogen Peroxide - pharmacology | Rats | Mitochondria - metabolism | Mitochondria - drug effects | Niacin - chemistry | Niacin - analogs & derivatives | Phosphates - metabolism | Animals | Brain Ischemia - pathology | Cerebellum - cytology | Benzodiazepines - chemistry | Oxidative Stress - drug effects | Cytochrome c | Hydrogen peroxide | Biochemistry | Mitochondrial DNA | Permeability | Glutamate | Benzodiazepines
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 2/2000, Volume 17, Issue 2, pp. 209 - 215
Purpose. The purpose of this study was to elucidate the mechanismsby which an HMG-CoA reductase inhibitor, atorvastatin (an organicacid with a pKa of 4.46),... 
Biochemistry, general | Biomedical Engineering | P-glycoprotein | Biomedicine | Caco-2 | Pharmacy | Atorvastatin | Medical Law | monocarboxylic acid transporter | Pharmacology/Toxicology | Monocarboxylic acid transporter | INTESTINAL TRANSPORT | REDUCTASE | PHARMACOLOGY & PHARMACY | atorvastatin | CHEMISTRY, MULTIDISCIPLINARY | Protons | ATP Binding Cassette Transporter, Subfamily B, Member 1 - pharmacology | Anion Transport Proteins | Pyrroles - pharmacokinetics | Cyclosporine - pharmacology | Heptanoic Acids - pharmacokinetics | Humans | Carboxylic Acids - pharmacokinetics | Hydroxymethylglutaryl-CoA Reductase Inhibitors - chemistry | Niacin - pharmacology | Vinblastine - pharmacokinetics | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Drug Interactions | Indicators and Reagents - pharmacology | Caco-2 Cells - metabolism | Biological Transport - drug effects | Cell Polarity - drug effects | Antineoplastic Agents, Phytogenic - pharmacokinetics | Immunosuppressive Agents - pharmacology | Ionophores - pharmacology | Benzoic Acid - pharmacology | Acetic Acid - pharmacology | Calcium Channel Blockers - pharmacology | Verapamil - pharmacology | Carrier Proteins - metabolism | Heptanoic Acids - chemistry | Pyrroles - chemistry | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone - pharmacology | Caco-2 Cells - chemistry | Carbon Radioisotopes | Hydrogen-Ion Concentration
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 10/2014, Volume 740, pp. 683 - 689
Journal Article
Molecular Nutrition & Food Research, ISSN 1613-4125, 08/2017, Volume 61, Issue 8, pp. 1600824 - n/a
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 06/2014, Volume 16, Issue 6, pp. 537 - 544
Journal Article
Journal Article
Journal Article